We are very pleased with these new orders and the steady growth of B&W’s nuclear product line for the U.S. government,” said Winfred Nash, President of Babcock & Wilcox Nuclear Operations Group
– By Stephen Heiser –
McDermott International, Inc. has announced that The Babcock & Wilcox Company (“B&W”), through a subsidiary, has received an award of approximately $450 million for the manufacture of nuclear components to support U.S. defense programs, including the manufacture of U.S. Naval nuclear power systems for submarines and aircraft carriers. The value of this contract was recorded in McDermott’s Government Operations segment backlog during the fourth quarter 2009.
“We are very pleased with these new orders and the steady growth of B&W’s nuclear product line for the U.S. government,” said Winfred Nash, President of Babcock & Wilcox Nuclear Operations Group. “B&W has long played an important role in supporting the defense of our nation, and we continue to be committed to that mission by providing reliable, cost effective and technologically advanced nuclear products.”
McDermott is an engineering and construction company, with specialty manufacturing and service capabilities, focused on energy infrastructure. McDermott’s customers are predominantly utilities and other power generators, major and national oil companies, and the United States Government. With its global operations, McDermott operates in over 20 countries with more than 25,000 employees.
Earlier this week Babcock & Wilcox Technical Services Group, Inc. (B&W TSG) was awarded approximately $9 million from the National Nuclear Security Administration (NNSA) for the company’s medical isotope production program. Awarded under a cooperative agreement, the funding will be used for further development of B&W TSG’s patented reactor technology for medical isotope production using low enriched uranium. B&W TSG is an operating unit of The Babcock & Wilcox Company.